NF
Neil Floch MD
@neilflochmd.bsky.social
Bariatric and Foregut Surgeon passionate about educating and advocating about obesity causes and treatments including medications and bariatric surgery - Associate Professor of Surgery Yale School of Medicine and a self-taught artist - Tufts Graduate in A
97 followers309 following25 posts
The change in %TBWL from baseline to 56-weeks was -8.8% (8.5, -29.2–9.7) and 1.1% (3.5, -7.9–5.99) in the #liraglutidewww.soard.org/article/S155...
A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0mg for weight recurrence after Roux-en-Y gastric-bypass
Bariatric surgery, such as Roux-en-Y gastric-bypass(RYGB) remains the gold standard for treating obesity. Most people regain weight from post-surgery nadir.
NF
Neil Floch MD
@neilflochmd.bsky.social
Bariatric and Foregut Surgeon passionate about educating and advocating about obesity causes and treatments including medications and bariatric surgery - Associate Professor of Surgery Yale School of Medicine and a self-taught artist - Tufts Graduate in A
97 followers309 following25 posts